Marco Frontoni

Pubblicazioni

Titolo Pubblicato in Anno
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL 2022
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study NEUROLOGICAL SCIENCES 2020
Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers JOURNAL OF NEUROLOGY 2020
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients SCIENTIFIC REPORTS 2019
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority FRONTIERS IN NEUROLOGY 2019
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus BIOMED RESEARCH INTERNATIONAL 2018
Photophobia in multiple sclerosis MULTIPLE SCLEROSIS AND RELATED DISORDERS 2018
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis NEUROLOGY 2016
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis MULTIPLE SCLEROSIS 2016
Cost minimization analysis of BoNT-As in the treatment of upper limb spasticity and cervical dystonia GLOBAL AND REGIONAL HEALTH TECHNOLOGY ASSESSMENT 2016

ERC

  • LS5_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Biomarrkers in Sclerosi multipla

Terapia dela sclerosi multipla

Applicazioni terapeutiche della tossina botulinica 

Terapia della spasticità

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma